Tidal Investments LLC lessened its holdings in Incannex Healthcare Inc. (NASDAQ:IXHL – Free Report) by 53.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 130,026 shares of the company’s stock after selling 150,590 shares during the quarter. Tidal Investments LLC owned approximately 0.74% of Incannex Healthcare worth $259,000 at the end of the most recent quarter.
Separately, Virtu Financial LLC purchased a new position in shares of Incannex Healthcare in the 3rd quarter valued at about $73,000. 0.43% of the stock is owned by institutional investors.
Incannex Healthcare Stock Performance
Shares of NASDAQ IXHL opened at $1.75 on Wednesday. The stock’s 50-day simple moving average is $2.08 and its 200-day simple moving average is $2.17. The firm has a market capitalization of $30.88 million, a PE ratio of -1.26 and a beta of 7.68. Incannex Healthcare Inc. has a fifty-two week low of $1.50 and a fifty-two week high of $8.47.
Incannex Healthcare Profile
Incannex Healthcare Inc, a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It develops products for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, pain, and other indications.
Read More
- Five stocks we like better than Incannex Healthcare
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- 3 Warren Buffett Stocks to Buy Now
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- What Are Dividends? Buy the Best Dividend Stocks
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for Incannex Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Incannex Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.